[go: up one dir, main page]

HUP9900511A3 - Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating - Google Patents

Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating

Info

Publication number
HUP9900511A3
HUP9900511A3 HU9900511A HUP9900511A HUP9900511A3 HU P9900511 A3 HUP9900511 A3 HU P9900511A3 HU 9900511 A HU9900511 A HU 9900511A HU P9900511 A HUP9900511 A HU P9900511A HU P9900511 A3 HUP9900511 A3 HU P9900511A3
Authority
HU
Hungary
Prior art keywords
cosmetical
beta
treating
adrenergic agonist
substance antagonist
Prior art date
Application number
HU9900511A
Other languages
English (en)
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of HUP9900511A2 publication Critical patent/HUP9900511A2/hu
Publication of HUP9900511A3 publication Critical patent/HUP9900511A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HU9900511A 1995-10-23 1996-10-01 Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating HUP9900511A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512447A FR2740040B1 (fr) 1995-10-23 1995-10-23 Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (2)

Publication Number Publication Date
HUP9900511A2 HUP9900511A2 (hu) 1999-07-28
HUP9900511A3 true HUP9900511A3 (en) 2000-09-28

Family

ID=9483809

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900511A HUP9900511A3 (en) 1995-10-23 1996-10-01 Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating

Country Status (14)

Country Link
US (2) US5958432A (hu)
EP (1) EP0769293B1 (hu)
JP (1) JP3636473B2 (hu)
AR (1) AR004052A1 (hu)
BR (1) BR9611302A (hu)
CA (1) CA2222311C (hu)
DE (1) DE69603681T2 (hu)
DK (1) DK0769293T3 (hu)
FR (1) FR2740040B1 (hu)
HU (1) HUP9900511A3 (hu)
NO (1) NO312273B1 (hu)
PL (1) PL186366B1 (hu)
RU (1) RU2169552C2 (hu)
WO (1) WO1997015281A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948972A (en) * 1994-12-22 1999-09-07 Kla-Tencor Corporation Dual stage instrument for scanning a specimen
US6503953B2 (en) 2000-07-26 2003-01-07 Atopic Pty Ltd. Methods for treating atopic disorders
ITPD20010187A1 (it) * 2001-07-23 2003-01-23 Cutech Srl Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (en) * 2001-09-21 2003-03-26 Boehringer Ingelheim International GmbH Method for the treatment of prevention of atopic dermatitis
US20030219573A1 (en) * 2002-03-27 2003-11-27 Torgny Falk Absorbent product
US7345065B2 (en) * 2002-05-21 2008-03-18 Allergan, Inc. Methods and compositions for alleviating pain
RU2220738C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Средство для лечения ринита
US8343519B2 (en) * 2003-02-19 2013-01-01 L'oreal S.A. Chemical enhancer and method
US20040209850A1 (en) * 2003-04-15 2004-10-21 Theraquest Biosciences, Llc Methods of treating pain and compositions for use therefor
WO2006054513A1 (ja) * 2004-11-19 2006-05-26 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療剤
JP5021621B2 (ja) 2005-04-13 2012-09-12 アスション ファーマ エー／エス 皮膚の結合組織病を治療するためのβ−２アドレナリン受容体作動薬
ES2375924T3 (es) * 2008-01-18 2012-03-07 Centre National De La Recherche Scientifique - Cnrs Agonistas beta-2 adrenérgicos para su utilización en el tratamiento de la alodinia neurop�?tica crónica.
GB0805535D0 (en) 2008-03-27 2008-04-30 Univ Leicester Scar prevention
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
AU2010217615C1 (en) * 2009-02-24 2013-05-23 Novartis Ag Uses of NK receptor antagonists
GB2513297A (en) 2013-03-08 2014-10-29 Univ Leicester Methods
US9937117B2 (en) 2015-07-09 2018-04-10 Galderma S.A. Method of reducing hair loss associated with chemotherapy
JP7152051B2 (ja) * 2018-05-29 2022-10-12 株式会社ナノエッグ アトピー性皮膚炎を治療または予防するための組成物
WO2020051568A1 (en) * 2018-09-08 2020-03-12 Wen Tan NEW USE OF R-ENANTIOMER OF ADRENERGIC β2 RECEPTOR AGONISTS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ITS EXTRA INTESTINAL MANIFESTATIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5366731A (en) * 1990-08-24 1994-11-22 Wisconsin Alumni Research Foundation Cosmetic compositions containing secosterol compounds
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) * 1994-03-18 1995-10-09 Kao Corp 浴用剤組成物
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

Also Published As

Publication number Publication date
EP0769293B1 (fr) 1999-08-11
JP2000503628A (ja) 2000-03-28
MX9710475A (es) 1998-08-30
NO312273B1 (no) 2002-04-22
PL186366B1 (pl) 2003-12-31
DE69603681D1 (de) 1999-09-16
EP0769293A3 (fr) 1997-05-02
CA2222311A1 (fr) 1997-05-01
BR9611302A (pt) 1999-03-30
AR004052A1 (es) 1998-09-30
CA2222311C (fr) 2006-11-28
PL324924A1 (en) 1998-06-22
US5958432A (en) 1999-09-28
WO1997015281A1 (fr) 1997-05-01
DE69603681T2 (de) 1999-11-25
NO976143D0 (no) 1997-12-30
EP0769293A2 (fr) 1997-04-23
NO976143L (no) 1998-06-03
US6267972B1 (en) 2001-07-31
FR2740040B1 (fr) 1997-12-05
JP3636473B2 (ja) 2005-04-06
RU2169552C2 (ru) 2001-06-27
HUP9900511A2 (hu) 1999-07-28
FR2740040A1 (fr) 1997-04-25
DK0769293T3 (da) 1999-12-06

Similar Documents

Publication Publication Date Title
HUP9900511A3 (en) Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating
IL117177A0 (en) Benzopyran-containing compounds and method for their use
EP0874828A4 (en) PAIN TREATMENT COMPOSITIONS
HUP9700559A3 (en) Method for analysing condition of machines
HUP9600255A1 (en) Various forms of paroxetin hydrochloride and process for their preparation
IL123166A0 (en) Method and composition for treating asthma
HUP9904009A3 (en) Method and novel compounds for use therein
EP0784464A4 (en) COMPOSITION AND METHOD FOR HAIR TREATMENT
ZA986206B (en) Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
IL132363A0 (en) Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
PL307669A1 (en) Benzimidazoles, therapeutic agents containing them and method of obtaining such compounds
GB2272852B (en) Method of and machine for grinding cams
ITTO950655A0 (it) Procedimento e macchina per trafilare
HU9702039D0 (en) Estrogen agonist/antagonists treatment of atheroscerosis
ZA964562B (en) Antipsychotic agents compositions and method of use
EP0711705A3 (en) Method and device for wrapping tampons
PL327600A1 (en) Method of treating depressions
PL349514A1 (en) Agents and method for treating keratinous fibres
GB2293835B (en) Tufting process and tufting device suitable for implementation of this process
HU9503622D0 (en) Use of p antagonist for treating pruritis, eye- and eyelid-acs and eye- or eyelid dysaesthesia
GB2332452B (en) Apparatus and method for grinding the clothing of a carding cylinder
IL124786A0 (en) Method for treating pain
HUP9901177A3 (en) Fungicide mixtures and process for their use
IL124419A0 (en) Composition for treating pain
GB2302677B (en) Wrapping machine and method

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees